Local antibiotic prophylaxis in inguinal hernia repair

Area of Science:

• Surgical Infection Prevention
• Clinical Pharmacology
• Evidence-Based Medicine

Background:

• Surgical site infections (SSIs) are a significant cause of patient morbidity and healthcare costs.
• The efficacy and cost-effectiveness of localized antibiotic prophylaxis for SSIs require further investigation.

Purpose of the Study:

• To evaluate the effectiveness of a single intraoperative dose of cefamandole for preventing surgical wound infections.
• To assess the safety and economic impact of this prophylactic antibiotic strategy.

Main Methods:

• A randomized controlled trial involving 324 patients undergoing surgery.
• Comparison of intraoperative wound delivery of cefamandole (750 mg) versus a control group receiving no antibiotics.
• Monitoring for wound abscesses and adverse events post-surgery.

Main Results:

• No wound abscesses were observed in the cefamandole prophylaxis group (n=162) compared to seven in the control group (n=162).
• The difference in wound abscesses between groups was statistically significant (p = 0.007).
• Six of the seven abscesses in the control group manifested late, after hospital discharge.
• The cost of antibiotic prophylaxis was ten times lower than the cost of treating wound complications.

Conclusions:

• Intraoperative localized cefamandole prophylaxis is highly effective in preventing surgical wound abscesses.
• This prophylactic approach is safe, with no observed adverse effects.
• Localized antibiotic prophylaxis offers significant cost savings by reducing the incidence of costly surgical site infections.